Precise Healthcare Solutions, Solutions for Precise Healthcare Management| Capitalbio

Solutions for Precise Healthcare Management CapitalBio

Precise healthcare refers to the delivery of accurate and personalized healthcare services based on individual needs. Precise healthcare solution involves utilizing advanced diagnostic tools, evidence-based practices, and precision medicine approaches to provide the most effective and targeted treatments for patients. GWAS is to detect molecular markers of genetic variation(such as SNPs) in the whole genome and to find its genetic correlation with observable traits/diseases, the prediction, and prevention of chronic diseases are of great significance. At present, scientists from various countries have carried out a large number of GWAS studies in a variety of complex diseases, and have achieved significant results in the study of genetic susceptibility genes of complex diseases such as tumors, cardiovascular and cerebrovascular diseases, autoimmunity, and immune-related diseases. As a leader in domestic biochips, Capital Biotech has led or participated in GWAS research on Chinese populations with various diseases, and relevant results have been published in top international journals. By establishing a mathematical model of susceptibility loci and disease risk, the risk of these diseases can be predicted.

Types Of Precise Healthcare Solutions

The Disease Susceptibility Genetic Test-Lung Cancer

This test bases on biochip technology, evaluates the risk of lung cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Liver Cancer

This test bases on biochip technology, evaluates the risk of liver cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Stomach Cancer

This test bases on biochip technology, evaluates the risk of stomach cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Breast Cancer

The test is based on biochip technology，evaluates the risk of breast cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Colorectal Cancer

The test is based on biochip technology, evaluates the risk of colorectal cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Esophageal Cancer

This test bases on biochip technology evaluates the risk of esophageal cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-High Incidence Cancer (6 Items)

This test bases on biochip technology, evaluates the risk of high-incidence cancers from the perspective of genetics, and provide guidance to disease prevention.

The Disease Susceptibility Genetic Test-High Incidence Cancer (10 Items)

This test bases on biochip technology, evaluates the risk of high-incidence cancers from the perspective of genetics, and provide guidance to disease prevention.

The Disease Susceptibility Genetic Test-Cancer Screening Package (29 Items)

This test is based on biochip technology to evaluate the risk of 29 high-incidence cancers from the perspective of genetics, and provide guidance to disease prevention.

The Disease Susceptibility Genetic Test-Anti-Cancer Package A

The test is based on biochip technology, by detecting the susceptibility loci on the TP53 gene that are closely related to tumorigenesis, it evaluates its influence on the risk of male tumors and female tumors.

The Disease Susceptibility Genetic Test-Anti-Cancer Package C

This test is based on biochip technology. By detecting TP53, CYP1A1 and XRCC1, assessing their impact on the risk of tumors.

The Disease Susceptibility Genetic Test-Alzheimer's Disease

This test is based on biochip technology to evaluate the risk of Alzheimer's disease by detecting the innate susceptibility genes of the human body.

The Disease Susceptibility Genetic Test-Cardiovascular Protection

This test bases on biochip technology, evaluate the risk of three thrombotic diseases from the perspective of genetics.

The Disease Susceptibility Genetic Test-Thrombotic Disorders (5 Items)

This test bases on biochip technology, evaluates the risk of five thrombotic diseases from the perspective of genetics.

The Disease Susceptibility Genetic Test-Diabetes (4 Items)

This test bases on biochip technology, from the genetic point of view, assess the risk of type 2 diabetes and its complications, and the sensitivity of hypoglycemic drugs.

The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items)

This test bases on biochip technology, evaluate the risk of 14 cardiovascular and cerebrovascular diseases from the perspective of genetics and guide disease prevention.

The Disease Susceptibility Genetic Test-Chronic Disease Package (34 Items)

This test bases on biochip technology, evaluates the risk of 34 chronic diseases from the perspective of genetics, and provide guidance to disease prevention.

The Disease Susceptibility Genetic Test-Chronic Disease Package (63 Items)

This test bases on biochip technology, evaluates the risk of 63 chronic diseases from the perspective of genetics, and provide guidance to disease prevention.

The Disease Susceptibility Genetic Test-APOE

The test is based on biochip technology. By detecting two gene loci that determine APOE protein polymorphism, it evaluates its impact on the risk of cardiovascular and cerebrovascular diseases, metabolic diseases.

The Disease Susceptibility Genetic Test-ADIPO

This test is based on biochip technology to evaluate its influence on cardiovascular and cerebrovascular diseases, metabolic diseases, tumors and other diseases by detecting two loci of the adiponectin gene.

The Disease Susceptibility Genetic Test-Full Package (150 Items)

This test bases on biochip technology, evaluates the risk of nearly 150 diseases in 13 categories from the perspective of genetics.

The Disease Susceptibility Genetic Test-Obesity

This test bases on biochip technology, evaluates the genetic risk of obesity, the effect of different nutrients in the diet, different exercise methods on the weight loss effect by detecting the genes related to the occurrence of obesity in the human body.

The Disease Susceptibility Genetic Test-High Myopia

This test bases on biochip technology, evaluates the risk of high myopia by detecting the innate susceptibility genes of the human body.

Metabolic Testing-Alcohol Metabolism Test

This test detects the genes related to alcohol metabolism in the human body, evaluates the alcohol metabolism ability of the subject.

Metabolic Testing-Tobacco Damage

This test detects the metabolic process of chemical substances in tobacco and the genes related to the damage mechanism to the human body.

Metabolic Testing-Alcohol Damage

This test detects the metabolic process of chemical substances in alcohol and the genes related to the damage mechanism in the human body.

Metabolic Testing-Food Intolerance (50 Items)

It is suitable for 9 common recipe categories (egg and milk, grain and nuts, meat, seafood, vegetables, fruit, yeast and beverage, seasoning, traditional Chinese medicine) based on the microarray platform, a total of 50 kinds of foods are tested for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.

Metabolic Testing-Food Intolerance (101 Items)

It is suitable for 9 common recipe categories (egg and milk, grain and nuts, meat, seafood, vegetables, fruit, yeast and beverage, seasoning, traditional Chinese medicine) based on the microarray platform, a total of 101 kinds of foods are tested for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.

Intestinal Flora Testing

Intestinal flora testing uses next-generation high-throughput sequencing platform, based on the 16S rDNA sequencing technology in the Human Microbiome Project.

Why Is Disease Susceptibility Genetic Test Important？

Genes are internal factors that affect or even determine human health, and genes associated with the disease are called disease susceptibility genes. Due to the differences between the genes of different individuals, some people are naturally prone to certain diseases, that is, they carry susceptibility genotypes related to the occurrence of diseases. When these susceptible people are exposed to adverse factors in the environment, their disease incidence rate is higher than people who do not carry the disease susceptibility genotype. Therefore, during precise healthcare sequencing solutions understanding the disease susceptibility genes in the human body can help predict the risk of disease occurrence.